A vaccine targeting resistant tumours by dual T cell plus NK cell attack.
Nature. 2022 Jun;606(7916):992-998. doi: 10.1038/s41586-022-04772-4. Epub 2022 May 25.
Nature. 2022.
PMID: 35614223